Evidence of active transport involvement in morphine transport via MDCKII and MDCK-PGP cell lines

Research in Pharmaceutical Sciences

Volumn 5, Issue 2, 2010, Pages 99-106

  Mashayekhi, Simin O ^a   Sattari, M R ^b   Routledge, P A ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Morphine transport; Multidrug resistance related protein; P glycoprotein; Probenecid sensitive transport

Indexed keywords

CYCLOSPORIN; DIGOXIN; GLUCOSE; GLYCOPROTEIN P; MORPHINE; PROBENECID;

ACTIVE TRANSPORT; ANIMAL CELL; ARTICLE; CELL STRAIN; CELL STRAIN MDCK PGP; CELL STRAIN MDCKII; CELL TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG PENETRATION; DRUG POTENTIATION; DRUG TRANSPORT; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN;

EID: 79953174932     PISSN: 17355362     EISSN: 17359414     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Brodie B, Kurz H, Schanker L. The importance of dissociation constant and lipid solubility in influencing the passage of drugs into the cerebrospinal fluid. J Pharmacol Exp Ther. 1960;130:20-25.
2. Schanker LS. Passage of drugs into and out of the central nervous system. Antimicrob Agents Chemother. 1965;5:1044-1050.
3. Oldendorf WH, Hyman S, Braun L, Oldendorf SZ. Blood-brain barrier: penetration of morphine, codeine, heroin, and methadone after carotid injection. Science. 1972;178:984-986.
4. Lotsch J, Schmidt R, Vetter G, Schmidt H, Niederberger E, Geisslinger G, et al. Increased CNS uptake and enhanced antinociception of morphine-6- glucuronide in rats after inhibition of P-glycoprotein. J Neurochem. 2002a;83:241-248. (Pubitemid 35191390)
5. Campbell WI. Rectal controlled-release morphine: plasma levels of morphine and its metabolites following the rectal administration of MST Continus 100 mg. J Clin Pharm Ther. 1996;21:65-71. (Pubitemid 26201737)
6. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR, Melamed MR. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem. 1990;38:1277-1287. (Pubitemid 20266126)
7. Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol. 2002;249:9-17. (Pubitemid 34119018)
8. Chong MS, Bajwa ZH. Diagnosis and treatment of neuropathic pain. J Pain Symptom Manage. 2003;25 (Suppl 5):S4-S11. (Pubitemid 36411836)
9. Campa D, Gioia A, Tomei A, Poli P, Barale R. Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. Clin Pharmacol Ther. 2008;83:559-566. (Pubitemid 351417058)
10. Wu D, Kang YS, Bickel U, Pardridge WM. Bloodbrain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine. Drug Metab Dispos. 1997;25:768-771. (Pubitemid 27259979)
11. Matos F, Rollema H, Taiwo Y, Levine J, Basbaum A. Relationship between analgesia and extracellular morphine in brain and spinal cord in awake rats. Brain Res. 1995;693:187-195.
12. Mashayekhi SO, Ghandforoush-Sattari M, Hain RD. Rapid and sensitive quantitation of morphine using HPLC with electrochemical detection. J Clin Pharm Ther. 2008;33:419-427.
13. Huwyler J, Drewe J, Gutmann H, Thole M, Fricker G. Modulation of morphine-6-glucuronide penetration into the brain by P-glycoprotein. Int J Clin Pharmacol Ther. 1998;36:69-70. (Pubitemid 28059629)
14. Campbell L, Abulrob AN, Kandalaft LE, Plummer S, Hollins AJ, Gibbs A, et al. Constitutive expression of p-glycoprotein in normal lung alveolar epithelium and functionality in primary alveolar epithelial cultures. J Pharmacol Exp Ther. 2003;304:441-452. (Pubitemid 36008958)
15. Tiberghien F, Loor F. Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay. Anticancer Drugs. 1996;7:568-578. (Pubitemid 26276348)
16. del Moral RG, Olmo A, Aguilar M, O'Valle F. P glycoprotein: a new mechanism to control drug-induced nephrotoxicity. Exp Nephrol. 1998;6:89-97. (Pubitemid 28140989)
17. Wandel C, Kim R, Wood M, Wood A. Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein. Anesthesiology. 2002;96:913-920. (Pubitemid 34266685)
18. Letrent SP, Polli JW, Humphreys JE, Pollack GM, Brouwer KR, Brouwer KL. P-glycoprotein-mediated transport of morphine in brain capillary endothelial cells. Biochem Pharmacol. 1999;58:951-957. (Pubitemid 29361461)
19. Groenendaal D, Freijer J, de Mik D, Bouw MR, Danhof M, de Lange EC. Population pharmacokinetic modelling of non-linear brain distribution of morphine: influence of active saturable influx and P-glycoprotein mediated efflux. Br J Pharmacol. 2007;151:701-712. (Pubitemid 47016288)
20. Xie R, Bouw MR, Hammarlund-Udenaes M. Modelling of the blood-brain barrier transport of morphine-3-glucuronide studied using microdialysis in the rat: involvement of probenecid-sensitive transport. Br J Pharmacol. 2000;131:1784-1792. (Pubitemid 32056446)
21. Seelbach MJ, Brooks TA, Egleton RD, Davis TP. Peripheral inflammatory hyperalgesia modulates morphine delivery to the brain: a role for P-glycoprotein. J Neurochem. 2007;102:1677-1690. (Pubitemid 47256196)
22. Kodawara T, Masuda S, Wakasugi H, Uwai Y, Futami T, Saito H, et al. Organic anion transporter oatp2-mediated interaction between digoxin and amiodarone in the rat liver. Pharm Res. 2002;19:738-743. (Pubitemid 34686731)
23. Bourasset F, Cisternino S, Temsamani J, Scherrmann JM. Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein- mediated at the blood-brain barrier. J Neurochem. 2003;86:1564-1567. (Pubitemid 37174273)
24. Bell GI, Burant CF, Takeda J, Gould GW. Structure and function of mammalian facilitative sugar transporters. J Biol Chem. 1993;268:19161-19164. (Pubitemid 23270678)
25. Polt R, Porreca F, Szabo LZ, Bilsky EJ, Davis P, Abbruscato TJ, et al. Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier. Proc Natl Acad Sci U S A. 1994;91:7114-7118. (Pubitemid 24226813)
26. Aasmundstad TA, Ripel A, Bodd E, Bjorneboe A, Morland J. Different biotransformation of morphine in isolated liver cells from guinea pig and rat. Biochem Pharmacol. 1993;46:961-968. (Pubitemid 23280536)
27. Mashayekhi SO, Ghandforoush-Sattari M, Routledge PA, Hain RD. Pharmacokinetic and pharmacodynamic study of morphine and morphine 6-glucuronide after oral and intravenous administration of morphine in children with cancer. Biopharm Drug Dispos. 2009;30:99-106.
28. Mashayekhi SO, Hain RD, Buss DC, Routledge PA. Morphine in children with cancer: impact of age, chemotherapy and other factors on protein binding. J Pain Palliat Care Pharmacother. 2007;21:5-12. (Pubitemid 47585214)